Analysis of CYP450gene allelic variants can predict ifosfamide toxicity in Mexican paediatric patients

AbstractContext:Ifosfamide (IFA) is an effective antineoplastic for solid tumours in children, although it is associated with high levels of systemic toxicity and causes death in some cases. Objective:The aim of this study was to determine whether the presence of certain allelic variants of genes CYP2B6, CYP2C9, CYP3A4and CYP3A5increases the risk of toxicity in children with solid tumours treated with ifosfamide.Materials and methods:A total of 131 DNA samples were genotyped by real-time polymerase chain reaction (RT-PCR) using TaqMan probes. Toxicity was assessed using WHO criteria, and survival analysis was performed using Kaplan–Meier curves.Results:The rs3745274 allelic variant in CYP2B6was associated with haematological toxicity, affecting neutrophils; CYP3A4variant rs2740574 was also associated with toxicity, affecting both leukocytes and neutrophils. Additionally, the CYP3A5gene variant rs776746 was found to affect haemoglobin.Conclusions:Our results show that allelic variants rs3745274 (CYP2B6), rs2740574 (CYP34)and rs776746 (CYP3A5)increase the risk for high haematological toxicity.Clinical trial registration:068/2013